Literature DB >> 21722265

Invasion front-specific expression and prognostic significance of microRNA in colorectal liver metastases.

Christoph Kahlert1, Fee Klupp, Karsten Brand, Felix Lasitschka, Sven Diederichs, Johanna Kirchberg, Nuh Rahbari, Shamik Dutta, Ulrich Bork, Johannes Fritzmann, Christoph Reissfelder, Moritz Koch, Juergen Weitz.   

Abstract

The tumor edge of colorectal cancer and its adjacent peritumoral tissue is characterized by an invasion front-specific expression of genes that contribute to angiogenesis or epithelial-to-mesenchymal transition. Dysregulation of these genes has a strong impact on the invasion behavior of tumor cells. However, the invasion front-specific expression of microRNA (miRNA) still remains unclear. Therefore, the aim of the present study was to investigate miRNA expression patterns at the invasion front of colorectal liver metastases. Laser microdissection of colorectal liver metastases was performed to obtain separate tissue compartments from the tumor center, tumor invasion front, liver invasion front and pure liver parenchyma. Microarray expression analysis revealed 23 miRNA downregulated in samples from the tumor invasion front with respect to the same miRNA in the liver, the liver invasion front or the tumor center. By comparing samples from the liver invasion front with samples from pure liver parenchyma, the tumor invasion front and the tumor center, 13 miRNA were downregulated. By quantitative RT-PCR, we validated the liver invasion front-specific downregulation of miR-19b, miR-194, let-7b and miR-1275 and the tumor invasion front-specific downregulation of miR-143, miR- 145, let-7b and miR-638. Univariate analysis demonstrated that enhanced expression of miR-19b and miR-194 at the liver invasion front, and decreased expression of let-7 at the tumor invasion front, is an adverse prognostic marker of tumor recurrence and overall survival. In conclusion, the present study suggests that invasion front-specific downregulation of miRNA in colorectal liver metastases plays a pivotal role in tumor progression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21722265     DOI: 10.1111/j.1349-7006.2011.02023.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  38 in total

Review 1.  MicroRNAs in colorectal cancer as markers and targets: Recent advances.

Authors:  Jing-Jia Ye; Jiang Cao
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

2.  CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set.

Authors:  William C Reinhold; Margot Sunshine; Hongfang Liu; Sudhir Varma; Kurt W Kohn; Joel Morris; James Doroshow; Yves Pommier
Journal:  Cancer Res       Date:  2012-07-15       Impact factor: 12.701

Review 3.  The role of vitamin D in hepatic metastases from colorectal cancer.

Authors:  E Shaw; N Massaro; N T Brockton
Journal:  Clin Transl Oncol       Date:  2017-08-11       Impact factor: 3.405

Review 4.  MicroRNAs in the p53 network: micromanagement of tumour suppression.

Authors:  Heiko Hermeking
Journal:  Nat Rev Cancer       Date:  2012-08-17       Impact factor: 60.716

Review 5.  MicroRNAs: relevant tools for a colorectal surgeon?

Authors:  Oliver Peacock; Andrew C Lee; Michael Larvin; Cristina Tufarelli; Jonathan N Lund
Journal:  World J Surg       Date:  2012-08       Impact factor: 3.352

6.  MicroRNA-638 is highly expressed in human vascular smooth muscle cells and inhibits PDGF-BB-induced cell proliferation and migration through targeting orphan nuclear receptor NOR1.

Authors:  Pan Li; Yan Liu; Bing Yi; Guokun Wang; Xiaohua You; Xianxian Zhao; Ross Summer; Yongwen Qin; Jianxin Sun
Journal:  Cardiovasc Res       Date:  2013-04-03       Impact factor: 10.787

Review 7.  Hepatic metastatic niche: from normal to pre-metastatic and metastatic niche.

Authors:  Shirin Azizidoost; Ahmad Ahmadzadeh; Fakher Rahim; Mohammad Shahjahani; Mohammad Seghatoleslami; Najmaldin Saki
Journal:  Tumour Biol       Date:  2015-12-11

8.  miR-19-Mediated Inhibition of Transglutaminase-2 Leads to Enhanced Invasion and Metastasis in Colorectal Cancer.

Authors:  A H Mirnezami; N J Peake; D Cellura; K Pickard; S Quaratino; H Parker; J C Strefford; G J Thomas; R Mitter
Journal:  Mol Cancer Res       Date:  2015-05-01       Impact factor: 5.852

9.  Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits.

Authors:  Ritu Jaiswal; Frederick Luk; Joyce Gong; Jean-Marie Mathys; Georges Emile Raymond Grau; Mary Bebawy
Journal:  Mol Cancer       Date:  2012-06-08       Impact factor: 27.401

10.  The expression level of miR-18b in hepatocellular carcinoma is associated with the grade of malignancy and prognosis.

Authors:  Yoshiki Murakami; Akihiro Tamori; Saori Itami; Toshihito Tanahashi; Hidenori Toyoda; Masami Tanaka; Weihong Wu; Nariso Brojigin; Yuji Kaneoka; Atsuyuki Maeda; Takashi Kumada; Norifumi Kawada; Shoji Kubo; Masahiko Kuroda
Journal:  BMC Cancer       Date:  2013-03-04       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.